AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 201 filers reported holding AMICUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $30,000 | -31.8% | 2,444 | -13.5% | 0.06% | -38.1% |
| Q2 2018 | $44,000 | +2.3% | 2,827 | 0.0% | 0.10% | -7.1% |
| Q1 2018 | $43,000 | +4.9% | 2,827 | 0.0% | 0.11% | +16.5% |
| Q4 2017 | $41,000 | +583.3% | 2,827 | +653.9% | 0.10% | +781.8% |
| Q3 2017 | $6,000 | -95.8% | 375 | -96.3% | 0.01% | -94.5% |
| Q3 2015 | $143,000 | -1.4% | 10,250 | 0.0% | 0.20% | +19.8% |
| Q2 2015 | $145,000 | +26.1% | 10,250 | -2.8% | 0.17% | +21.0% |
| Q1 2015 | $115,000 | +173.8% | 10,550 | +111.0% | 0.14% | +181.6% |
| Q4 2014 | $42,000 | +600.0% | 5,000 | +400.0% | 0.05% | +512.5% |
| Q3 2014 | $6,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |